ATE249442T1 - Polyhydroxyalkylpyrazine derivate, deren herstellung,diese enthaltende arzneimitteln - Google Patents

Polyhydroxyalkylpyrazine derivate, deren herstellung,diese enthaltende arzneimitteln

Info

Publication number
ATE249442T1
ATE249442T1 AT98939678T AT98939678T ATE249442T1 AT E249442 T1 ATE249442 T1 AT E249442T1 AT 98939678 T AT98939678 T AT 98939678T AT 98939678 T AT98939678 T AT 98939678T AT E249442 T1 ATE249442 T1 AT E249442T1
Authority
AT
Austria
Prior art keywords
formula
ch2oh
choh
compound
production
Prior art date
Application number
AT98939678T
Other languages
English (en)
Inventor
Georges Bashiardes
Jean-Christophe Carry
Michel Evers
Bruno Filoche
Serge Mignani
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of ATE249442T1 publication Critical patent/ATE249442T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/12—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
AT98939678T 1997-07-17 1998-07-15 Polyhydroxyalkylpyrazine derivate, deren herstellung,diese enthaltende arzneimitteln ATE249442T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9709060A FR2766184B1 (fr) 1997-07-17 1997-07-17 Medicaments contenant en tant que principe actif au moins un derive de polyhydroxylalkylpyrazine, les nouveaux derives de polyhydroxylalkylpyrazine et leur preparation
PCT/FR1998/001544 WO1999003842A1 (fr) 1997-07-17 1998-07-15 Derives de polyhydroxylalkylpyrazine, leur preparation, medicaments les contenant

Publications (1)

Publication Number Publication Date
ATE249442T1 true ATE249442T1 (de) 2003-09-15

Family

ID=9509303

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98939678T ATE249442T1 (de) 1997-07-17 1998-07-15 Polyhydroxyalkylpyrazine derivate, deren herstellung,diese enthaltende arzneimitteln

Country Status (24)

Country Link
US (2) US6392042B1 (de)
EP (1) EP0998465B1 (de)
JP (1) JP4443034B2 (de)
KR (1) KR20010021822A (de)
CN (1) CN1264370A (de)
AT (1) ATE249442T1 (de)
AU (1) AU751090B2 (de)
BR (1) BR9811013A (de)
CA (1) CA2296739C (de)
CZ (1) CZ290908B6 (de)
DE (1) DE69818060T2 (de)
DK (1) DK0998465T3 (de)
ES (1) ES2206978T3 (de)
FR (1) FR2766184B1 (de)
HU (1) HUP0002821A3 (de)
IL (1) IL134038A0 (de)
MX (1) MXPA00000252A (de)
NO (1) NO20000055L (de)
NZ (1) NZ502276A (de)
PL (1) PL338133A1 (de)
RU (1) RU2192420C2 (de)
SK (1) SK472000A3 (de)
WO (1) WO1999003842A1 (de)
ZA (1) ZA986334B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1704862A1 (de) * 2005-03-24 2006-09-27 Rottapharm S.p.A. 2,5-bis(tetrahydroxybutyl)pyrazin-Derivaten zur Behandlung von Osteoarthritis und rheumatoider Arthritis
CN100371330C (zh) * 2006-01-24 2008-02-27 湖南中烟工业公司 从糖氨反应液中分离提纯多羟基烷基吡嗪类化合物的方法
CN105294579B (zh) * 2015-11-27 2018-07-20 中国科学院山西煤炭化学研究所 一种利用甲壳素类生物质制备脱氧果糖嗪的方法
US11091446B2 (en) * 2017-03-24 2021-08-17 R.J. Reynolds Tobacco Company Methods of selectively forming substituted pyrazines

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL64267A (en) * 1980-12-09 1985-08-30 Erba Farmitalia Ethers of hydroxymethylpyrazin-n-oxides,their preparation and pharmaceutical compositions containing them
WO1995030660A1 (fr) * 1994-05-10 1995-11-16 Firmenich S.A. Procede pour la preparation de pyrazines substituees
DE19547543A1 (de) 1995-12-20 1997-06-26 Teves Gmbh Alfred Teilbelagscheibenbremse mit einem Schwimmsattel
FR2744365B1 (fr) * 1996-02-06 1998-02-27 Inst Malgache Rech Appl Melanges isolables a partir de graines d'eugenia jambolana lamarck, leur preparation et l'utilisation de ces melanges et certains de leurs constituants comme medicaments

Also Published As

Publication number Publication date
ES2206978T3 (es) 2004-05-16
US6392042B1 (en) 2002-05-21
DK0998465T3 (da) 2003-12-15
HUP0002821A3 (en) 2001-07-30
JP4443034B2 (ja) 2010-03-31
JP2001510186A (ja) 2001-07-31
AU8810498A (en) 1999-02-10
US20040209890A1 (en) 2004-10-21
RU2192420C2 (ru) 2002-11-10
CZ2000122A3 (cs) 2000-05-17
CN1264370A (zh) 2000-08-23
CZ290908B6 (cs) 2002-11-13
EP0998465B1 (de) 2003-09-10
PL338133A1 (en) 2000-09-25
WO1999003842A1 (fr) 1999-01-28
MXPA00000252A (es) 2002-04-24
IL134038A0 (en) 2001-04-30
HUP0002821A2 (hu) 2001-05-28
FR2766184A1 (fr) 1999-01-22
AU751090B2 (en) 2002-08-08
NO20000055D0 (no) 2000-01-06
CA2296739C (fr) 2008-09-23
ZA986334B (en) 1999-02-02
SK472000A3 (en) 2000-06-12
EP0998465A1 (de) 2000-05-10
DE69818060D1 (de) 2003-10-16
NO20000055L (no) 2000-01-06
NZ502276A (en) 2001-09-28
FR2766184B1 (fr) 2000-11-17
KR20010021822A (ko) 2001-03-15
DE69818060T2 (de) 2004-07-08
BR9811013A (pt) 2000-08-15
CA2296739A1 (fr) 1999-01-28

Similar Documents

Publication Publication Date Title
HUP9600448A2 (hu) Naftilvegyületek, e vegyületeket tartalmazó gyógyszerkészítmények, eljárás előállításukra, intermedierjeik és alkalmazásuk
LU91854I2 (fr) Eribulin et ses dérivés pharmaceutiquement acceptables (HALAVEN®)
MXPA04009784A (es) Tiazolidin-4-carbonitrilos y analogos y su uso como inhibidores de dipeptidil-peptidas.
ATE261435T1 (de) Benzofuranderivate, verfahren zu ihrer herstellung und deren verwendungen
GR3034650T3 (en) Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
SG49692A1 (en) Process for the production of a pharmaceutical agent for oral or topical administration in the treatment of leishmaniasis
WO1999012532A3 (en) Piperidine derivatives against malaria
ES2060173T3 (es) Derivados de lisolecitina para el tratamiento de enfermedades autoinmunologicas.
AU1302388A (en) Method of treating anxiety with tetrahydrobenz(c,d)indole-6- carboxamides
ATE206926T1 (de) Verwendung eines phosphorsäurediesters zur herstellung eines arzneimittels zur behandlung von akne
ATE180669T1 (de) Verwendung von pregnanderivaten zur behandlung von tumoren
DE69227583D1 (de) Arylmorpholine, herstellung und verwendung
DE69818060D1 (de) Polyhydroxyalkylpyrazine derivate, deren herstellung,diese enthaltende arzneimitteln
KR880007462A (ko) 빈뇨치료용 프로피오페논 유도체
ATE149165T1 (de) Stickstoff enthaltende bizyklische derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
ATE48276T1 (de) 1,6-naphthyridin-derivate, verfahren zu deren herstellung und diese enthaltende arzneimittel.
DE69917668D1 (de) Substanz gm-95, verfahren zu ihrer herstellung und ihre verwendung
PT90706A (pt) Processo para a preparacao de derivados de antraciclinas dotados de actividade citostatica
ATE252089T1 (de) Polyhydroxyalkylpyrazine derivate,deren herstellung und diese enthaltende arzneimitteln
DE69527789D1 (de) Mittel zur behandlung von kachexie die im zusammenhang mit tumoren steht
DE69908367D1 (de) Polyhydroxyalkylpyrazine derivate und deren herstellung und diese enthaltende arzneimittel
DE3776171D1 (de) 1-styrensulfonyl-2-oxo-5-hydroxy-pyrrolidine, ihre vorprodukte und verfahren zur herstellung, sie enthaltende zusammensetzungen und ihre anwendung als heilmittel.
JPS6422852A (en) Novel derivative of 1-arylsulfonyl-1,5-dihydro- 2h-pyrrole-2-one, manufacture and intermediate, use as drug and composition
TW200511994A (en) Novel compounds and therapeutic uses thereof

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties